Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Jun 26 | Jun 25 | |
|---|---|---|
| Revenue | $7.8B | $4.1B |
| YoY growth | +91.9% | — |
| Gross margin | — | — |
| Operating margin | -1.8% | -23.8% |
| Net income | -$541M | -$1.0B |
| Diluted EPS | -0.09 | -0.34 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
First tone reading · the comparison will come with the next 10-Q
10-Q of 2026-08-04 · 33.0% positive sentences, 14.9% negative · 261 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Coatue Management · Philippe Laffont
held since Q2 2026 |
6.5% | $3.2B | new |
| ARK Investment Management · Cathie Wood
held since Q2 2026 |
5.0% | $765.1M | new |
| Third Point · Dan Loeb
held since Q2 2026 |
0.7% | $30.8M | new |
| Viking Global · Andreas Halvorsen
held since Q2 2026 |
0.6% | $205.0M | new |
| Appaloosa · David Tepper
held since Q2 2026 |
0.5% | $38.4M | new |
| Tiger Global · Chase Coleman
held since Q2 2026 |
0.3% | $64.1M | new |
| Bridgewater Associates · Ray Dalio
held since Q2 2026 |
0.0% | $2.0M | new |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for SPCX →
| 2026-09-22 | Shotwell Gwynne · COO | Sell (10b5-1 plan) | $23.4M | SEC ↗ |
| 2026-09-22 | Shotwell Gwynne · COO | Sell (10b5-1 plan) | $22.3M | SEC ↗ |
| 2026-09-22 | Shotwell Gwynne · COO | Sell (10b5-1 plan) | $3.8M | SEC ↗ |
| 2026-09-22 | Shotwell Gwynne · COO | Sell (10b5-1 plan) | $1.9M | SEC ↗ |
| 2026-09-22 | Shotwell Gwynne · COO | Sell (10b5-1 plan) | $1.2M | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.